A phase 3 trial found that ubrogepant, given during the premonitory phase of migraine, improved common warning symptoms such ...

The study also found that the rate of serious adverse side effects occurs at 22 times the rate that the FDA-approved drug ...

A recent study conducted by the Ethics & Public Policy Center that found nearly 11% of women who used the popular abortion ...

Health and Human Services Secretary Robert F. Kennedy Jr. said Wednesday the Food and Drug Administration should change the ...